Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on May 31, 2025

La Corporation Trans Mountain annonce ses résultats financiers pour le premier trimestre de 2025

La Corporation Trans Mountain annonce ses résultats financiers pour le premier trimestre de 2025

CALGARY, Alberta, 30 mai 2025 (GLOBE NEWSWIRE) -- la Corporation Trans Mountain (la « CTM » ou la « société ») a publié ses états financiers et le rapport de la direction qui s’y rattache pour le trimestre clos le 31 mars 2025. Les résultats financiers de …

Trans Mountain Corporation Releases First Quarter 2025 Financial Results

Trans Mountain Corporation Releases First Quarter 2025 Financial Results

CALGARY, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- Trans Mountain Corporation (“TMC” or “the Company”) has released its financial statements and associated management report for the three months ending March 31, 2025. The Company’s financial results are …

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreated LTC residents are often given a broader diagnosis of extrapyramidal syndrome, …

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS…

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS…

Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED) visits versus second-generation daily oral options Latest Phase 3 SOLARIS data show no …

NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units

NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units

VANCOUVER, BC, May 30, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (the “Company” or “New Wave”) (CSE: NWAI, FWB: 0XM0, OTCPK: TRMNF) announces, further to its news release of May 20 and May 29, 2025, that the Company has closed the previously …

Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition

Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition

VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service